• Eamonn Hobbs, president and CEO of AngioDynamics (Queensbury, New York), was elected to theMedical Device Manufacturers Association(MDMA; Washington) board of directors at the organization’s annual meeting in Washington last month.

• Mark Ivie has been named chief technology officer of MedQuist (Mount Laurel, New Jersey), effective June 27. Ivie has significant healthcare IT experience, most recently as general manager, enterprise systems and technology for GE Healthcare. MedQuist, a Philips company, is a provider of electronic medical transcription, health information and document management products and services.

• Noven Pharmaceuticals (Miami), developer of transdermal drug delivery technologies and prescription transdermal products, has made two appointments. Jeffrey Eisenberg, formerly Noven’s vice president-strategic alliances and general counsel, has been appointed senior vice president-strategic alliances. Jeff Mihm, Noven’s assistant general counsel since 2003, will succeed Eisenberg as general counsel.

• Michael Murphy, PhD, has been named senior vice president of operations for Pacific Biometrics (PBI; Seat-tle). Murphy joins PBI from Laboratory Corp. of America, where he served as technical director responsible for three of its West Division labs. PBI provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting clinical trial research.